|1.||Ramjee, Gita: 4 articles (02/2015 - 11/2006)|
|2.||Donders, Gilbert: 4 articles (06/2014 - 01/2012)|
|3.||Hillier, Sharon L: 3 articles (04/2015 - 05/2006)|
|4.||Gut, Robert: 3 articles (10/2010 - 01/2008)|
|5.||Nachtigall, Lila: 3 articles (10/2010 - 01/2008)|
|6.||Milani, Massimo: 3 articles (06/2005 - 07/2003)|
|7.||Marrazzo, Jeanne: 2 articles (12/2015 - 07/2015)|
|8.||Prasauskas, V: 2 articles (10/2015 - 06/2013)|
|9.||Grob, P: 2 articles (10/2015 - 06/2013)|
|10.||Schwebke, Jane R: 2 articles (07/2015 - 04/2004)|
06/01/2005 - "We evaluated the efficacy of a mucoadhesive vaginal gel (MVG, Miphil) with acidic-buffering properties in bacterial vaginosis (BV). "
01/01/2009 - "The purpose of this study was to determine the effectiveness of Lactobacillus-containing vaginal tablets in the treatment of bacterial vaginosis (BV) and in the restoration of a healthy vaginal flora. "
04/01/1994 - "Within this study, women with bacterial vaginosis (16 to 27 week' gestation) were treated with 2% clinadmycin vaginal cream or placebo. "
11/01/2014 - "Effectiveness of the two microorganisms Lactobacillus fermentum LF15 and Lactobacillus plantarum LP01, formulated in slow-release vaginal tablets, in women affected by bacterial vaginosis: a pilot study."
06/30/2011 - "plantarum [FV9]), whose effectiveness in treating bacterial vaginosis in the form of vaginal tablets has been reported recently, prevented sperm lipid peroxidation that was induced in vitro by a ferrous ion promoter, thus preserving sperm motility and viability. "
03/01/2013 - "Effective treatment of vaginal atrophy with isoflavone vaginal gel."
11/01/2008 - "To evaluate the efficacy of ultra-low-dose 10-microgram 17beta-estradiol (E2) vaginal tablets for treatment of vaginal atrophy. "
01/01/2008 - "Vaginal tablets with 25 mcg and 10 mcg E2 provided relief of vaginal symptoms, improved urogenital atrophy, decreased vaginal pH, and increased maturation of the vaginal and urethral epithelium. "
01/01/2003 - "Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study."
12/01/2013 - "A new product, ZP-025 vaginal gel, containing purified (dialyzed lyophilized) bovine colostrum, has been developed for the treatment of vaginal dryness secondary to vaginal atrophy. "
01/01/2003 - "The twice-weekly local single treatment with vaginal tablets containing 25 microg of 17beta-oestradiol was effective and safe for the relief of symptoms related to atrophic vaginitis in postmenopausal women from the Greek population."
01/01/2005 - "Low-dose 17beta-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety."
01/01/2005 - "325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17beta-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks). "
01/01/2005 - "To verify the effectiveness and safety of low-dose 17beta-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. "
01/01/2005 - "Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets."
10/01/2014 - "But for vaginal gels to avert HIV and other sexually transmitted infections (STIs), at-risk women must be willing to use them as directed. "
09/15/2011 - "Due to the extensive use of copaiba oleoresin in the suppository form for gynecological infections, an evaluation was carried out on the effects of copaiba oleoresin (Copaifera duckei Dwyer), delivered in a vaginal cream, on the reproductive performance of female Wistar rats. "
12/01/2008 - "Development and in vitro evaluation of an acid buffering bioadhesive vaginal gel for mixed vaginal infections."
01/01/2007 - "An acid-buffering bioadhesive vaginal tablet was developed for the treatment of genitourinary tract infections. "
01/01/2007 - "Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections."
01/01/1983 - "A comparison of the efficacy of two vaginal creams for vulvovaginal candidiasis, and correlations with the presence of Candida species in the perianal area and oral contraceptive use."
03/01/2013 - "Our results show that vaginal cream, 1% Lamisil, could be suggested as a first-line treatment in vulvovaginal candidiasis."
01/01/2015 - "Therefore the objective of this study was to determine the effects of vaginal cream, mixture of yogurt and honey and comparing it with clotrimazole vaginal cream on symptoms of Vulvovaginal candidiasis in patients. "
05/01/2000 - "To determine the efficacy and safety of a single-dose (1200 mg) soft gel insert (vaginal ovule) with miconazole nitrate (2%) topical cream compared with Monistat 7 (miconazole nitrate 2%) Vaginal Cream (Advanced Care Products, North Brunswick NJ) in treating vulvovaginal candidiasis (VVC), two randomized, single-blind, multicenter, controlled, comparative phase III studies were performed. "
07/01/2015 - "For the treatment of vulvovaginal candidiasis, antifungal agents are used either as topical (vaginal tablets and cream) or oral formulations. "
|5.||Vaginal Creams, Foams, and Jellies (Vaginal Tablet)
|8.||Ascorbic Acid (Vitamin C)
|9.||Amphotericin B (Amphotericin)
|2.||Contraception (Birth Control)
|3.||Female Contraceptive Devices (Vaginal Ring)
|4.||Cesarean Section (Caesarean Section)